PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential.

about

PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential.

Item

http://www.wikidata.org/entity/Q48128686

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

PP2A deactivation is a common ...... omising therapeutic potential.

@en

PP2A deactivation is a common ...... omising therapeutic potential.

@nl

type

Item

label

PP2A deactivation is a common ...... omising therapeutic potential.

@en

PP2A deactivation is a common ...... omising therapeutic potential.

@nl

prefLabel

PP2A deactivation is a common ...... omising therapeutic potential.

@en

PP2A deactivation is a common ...... omising therapeutic potential.

@nl

P1476

PP2A deactivation is a common ...... omising therapeutic potential.

@en

P2093

Chien-Hung Lee

http://www.w3.org/2001/XMLSchema#string

Chun-Hung Hua

http://www.w3.org/2001/XMLSchema#string

Kun-Tu Yeh

http://www.w3.org/2001/XMLSchema#string

Mei-Chung Chen

http://www.w3.org/2001/XMLSchema#string

Shang-Lun Chiang

http://www.w3.org/2001/XMLSchema#string

Shu-Hui Lin

http://www.w3.org/2001/XMLSchema#string

Ying-Chin Ko

http://www.w3.org/2001/XMLSchema#string

P2860

Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta.

B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK

Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt

CIP2A inhibits PP2A in human malignancies

Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling

Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Promoter hypermethylation patterns of P16, DAPK and MGMT in oral squamous cell carcinoma: a systematic review and meta-analysis

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway

P304

1300-1311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.26001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

233

http://www.w3.org/2001/XMLSchema#string

P50

Bharath Kumar Velmurugan

P577

2017-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28516459

http://www.w3.org/2001/XMLSchema#string